The pharmaceutical industry is being under continuous pressure and ever-changing now more than ever. For those in regulatory affairs, there are numerous challenges as they plan their regulatory strategy. The current pandemic situation has shown that there is a need for improved collaboration not only with regulatory agencies, but also among pharmaceutical companies. Why do regulatory professionals have such a critical role? How does new European pharmaceutical strategy affect regulatory operations? And how can medical products and devices stay up to date in the age of advancing information technology?
The Pharmaceutical Regulatory Affairs Summit has been designed to introduce new challenges and opportunities of the European pharmaceutical strategy, share light on trends in data management for regulations processes, discuss the role of regulatory affairs, responsibilities of regulatory agencies, regulations of medical devices or upcoming future pharma legislations and much more. This event will provide you with valuable information and strategic visions from representatives of leading companies of the pharmaceutical market.
This business meeting is an excellent opportunity for valuable networking, ideas exchange and a place to gain inspiration from senior-level decision-makers. Learn, share and establish important business contacts with other regulatory professionals.
Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharmaceutical industry involved in: